UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 283

Sortiert nach

Supporting families on their journey towards a normal everyday life ‐ facilitating partnership in an early discharge program for families with premature infants

Journal for specialists in pediatric nursing, 2020-01, Vol.25 (1), p.e12274-n/a

2020

Volltextzugriff (PDF)

The effects of three silage inoculants on aerobic stability in grass, clover-grass, lucerne and maize silages

Agricultural and food science, 2013-01, Vol.22 (1), p.137-144

2013

Volltextzugriff (PDF)

A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

Gynecologic oncology, 2010-10, Vol.119 (1), p.26-31

2010

Volltextzugriff (PDF)

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial

Journal of clinical oncology, 2019-11, Vol.37 (32), p.JCO1802238-2973

2019

Volltextzugriff (PDF)

Radiobiological Impact of Reduced Margins and Treatment Technique for Prostate Cancer in Terms of Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP)

Medical dosimetry : official journal of the American Association of Medical Dosimetrists, 2011, Vol.36 (2), p.130-137

2011

Volltextzugriff (PDF)

Structural Determinants for the Mode of Action of Imidazopyridine DS2 at δ‑Containing γ‑Aminobutyric Acid Type A Receptors

Journal of medicinal chemistry, 2021-04, Vol.64 (8), p.4730-4743

2021

Volltextzugriff (PDF)

From Expressing Human Milk to Breastfeeding-An Essential Element in the Journey to Motherhood of Mothers of Prematurely Born Infants

Advances in neonatal care, 2022-12, Vol.22 (6), p.560

2022

Volltextzugriff (PDF)

Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

The lancet oncology, 2018-08, Vol.19 (8), p.1117-1125

2018

Volltextzugriff (PDF)

Long-term safety and secondary efficacy endpoints in the ENGOT-OV16/NOVA phase III trial of niraparib in recurrent ovarian cancer

Gynecologic oncology, 2021-08, Vol.162, p.S24-S25

2021

Volltextzugriff (PDF)

The PROMova study comparing active and passive use of patient-reported outcome measures in ovarian cancer follow-up: effect on patient-perceived involvement, satisfaction with care, and usefulness

Acta oncologica, 2021-04, Vol.60 (4), p.434-443

2021

Volltextzugriff (PDF)

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer

The New England journal of medicine, 2022-02, Vol.386 (7), p.704-704

2022

Volltextzugriff (PDF)

High consequence infectious diseases in Europe - the need for an expert clinical support service

Population medicine, 2023-04, Vol.5 (Supplement)

2023

Volltextzugriff (PDF)

Niraparib exposure-response relationship in patients (pts) with newly diagnosed advanced ovarian cancer (AOC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.6051-6051

2020

Volltextzugriff (PDF)

Rallying the Troops: How Sharing Knowledge With Grandparents Supports the Family of the Preterm Infant in Neonatal Intensive Care Unit

Advances in neonatal care, 2017-06, Vol.17 (3), p.E1

2017

Volltextzugriff (PDF)

Lungeembolisme ved covid-19

Tidsskrift for den Norske Lægeforening, 2020, Vol.140 (8)

2020

Volltextzugriff (PDF)

Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer: A randomized controlled chemotherapy-free study—NSGO-AVANOVA2/ENGOT-OV24

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.5505-5505

2019

Volltextzugriff (PDF)

Rettelse: Lungeembolisme ved covid-19

Tidsskrift for den Norske Lægeforening, 2021

2021

Volltextzugriff (PDF)

Postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer: The ENGOT-EN2/DGCG trial

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS5613-TPS5613

2017

Volltextzugriff (PDF)

Improved Classification of Epithelial Ovarian Cancer: Results of 3 Danish Cohorts

International journal of gynecological cancer, 2011-12, Vol.21 (9), p.1592-1600

2011

Volltextzugriff (PDF)

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

BMC cancer, 2014-12, Vol.14 (1), p.937-937, Article 937

2014

Volltextzugriff (PDF)

Correction: Pulmonary embolism in cases of COVID-19

Tidsskrift for den Norske Lægeforening, 2021-01, Vol.140 (1)

2021

Volltextzugriff (PDF)

Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer

Oncology letters, 2016-06, Vol.11 (6), p.3967-3974

2016

Volltextzugriff (PDF)

Pulmonary embolism in cases of COVID-19

Tidsskrift for den Norske Lægeforening, 2020-05, Vol.140 (8)

2020

Volltextzugriff (PDF)

1 – 25 von 283

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(269)
Mit Volltextzugriff
(249)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(207)
Life Sciences & Biomedicine
(197)
Humans
(138)
Female
(82)
Male
(80)
Middle Aged
(79)
Rheumatology
(68)
Adult
(60)
Aged
(49)
Patients
(45)
Rheumatoid Arthritis
(40)
Treatment Outcome
(33)
Arthritis
(27)
Registries
(27)
Antirheumatic Agents - Therapeutic Use
(26)
Inflammation
(26)
Medicin Och Hälsovetenskap
(26)
Biological And Medical Sciences
(24)
Animals
(20)
Denmark
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Supporting families on their journey towards a normal everyday life ‐ facilitating partnership in an early discharge program for families with premature infants

The effects of three silage inoculants on aerobic stability in grass, clover-grass, lucerne and maize silages

A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial

Radiobiological Impact of Reduced Margins and Treatment Technique for Prostate Cancer in Terms of Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP)

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

Structural Determinants for the Mode of Action of Imidazopyridine DS2 at δ‑Containing γ‑Aminobutyric Acid Type A Receptors

From Expressing Human Milk to Breastfeeding-An Essential Element in the Journey to Motherhood of Mothers of Prematurely Born Infants

Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

Long-term safety and secondary efficacy endpoints in the ENGOT-OV16/NOVA phase III trial of niraparib in recurrent ovarian cancer

The PROMova study comparing active and passive use of patient-reported outcome measures in ovarian cancer follow-up: effect on patient-perceived involvement, satisfaction with care, and usefulness

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer

High consequence infectious diseases in Europe - the need for an expert clinical support service

Niraparib exposure-response relationship in patients (pts) with newly diagnosed advanced ovarian cancer (AOC)

Rallying the Troops: How Sharing Knowledge With Grandparents Supports the Family of the Preterm Infant in Neonatal Intensive Care Unit

Final survival analysis of NSGO-AVANOVA2/ENGOT-OV24: Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer—A randomized controlled chemotherapy-free study

Lungeembolisme ved covid-19

Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer: A randomized controlled chemotherapy-free study—NSGO-AVANOVA2/ENGOT-OV24

Rettelse: Lungeembolisme ved covid-19

Postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer: The ENGOT-EN2/DGCG trial

Improved Classification of Epithelial Ovarian Cancer: Results of 3 Danish Cohorts

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

Correction: Pulmonary embolism in cases of COVID-19

Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer

Pulmonary embolism in cases of COVID-19

Suchergebnisse filtern